2型糖尿病中的姜黄素:调节代谢功能障碍的自然途径。

IF 2.1 Q3 PHARMACOLOGY & PHARMACY
Drug Research Pub Date : 2025-09-01 Epub Date: 2025-06-02 DOI:10.1055/a-2604-4115
Rufaida Wasim, Sumaiya Azmi, Mohammad Owais, Aamir Anwar
{"title":"2型糖尿病中的姜黄素:调节代谢功能障碍的自然途径。","authors":"Rufaida Wasim, Sumaiya Azmi, Mohammad Owais, Aamir Anwar","doi":"10.1055/a-2604-4115","DOIUrl":null,"url":null,"abstract":"<p><p>A complex and multifaceted metabolic disease, type 2 diabetes mellitus (T2DM) is becoming a significant public health concern. Due to their many biological characteristics, bioactive compounds from herbal medicine have been shown in multiple studies to have positive benefits on the prevention and control of type 2 diabetes. The scientific community is becoming more interested in curcumin, one of these therapeutic herbs. The plant Curcuma longa, often known as turmeric, has a bioactive compound called curcumin in its rhizome. Antioxidant, cardio-protective, anti-inflammatory, anti-microbial, nephro-protective, anti-neoplastic, hepato-protective, immunomodulatory, hypoglycemic, and anti-rheumatic effects are among the various pharmacological and biological effects of curcumin that have been reported by both in vitro and in vivo studies. Curcumin extract increases -cell functioning, delays the onset of diabetes, inhibits -cell death, and lowers insulin resistance in animal models. Recent preclinical studies and clinical trials have shown strong evidence of curcumin's vital roles in preventing type 2 diabetes via a number of pathways. Thus, the antidiabetic action of curcumin and its many mechanisms are comprehensively summarized in this study. The findings indicated that curcumin's anti-inflammatory, anti-oxidant, antihyperglycemic, antiapoptotic, and antihyperlipidemic properties, among others, account for its success in treating type 2 diabetes. These findings suggest that curcumin could be a potential option for T2DM prevention and management.</p>","PeriodicalId":11451,"journal":{"name":"Drug Research","volume":" ","pages":"251-260"},"PeriodicalIF":2.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Curcumin in Type 2 Diabetes Mellitus: A Natural Approach to Modulating Metabolic Dysfunction.\",\"authors\":\"Rufaida Wasim, Sumaiya Azmi, Mohammad Owais, Aamir Anwar\",\"doi\":\"10.1055/a-2604-4115\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A complex and multifaceted metabolic disease, type 2 diabetes mellitus (T2DM) is becoming a significant public health concern. Due to their many biological characteristics, bioactive compounds from herbal medicine have been shown in multiple studies to have positive benefits on the prevention and control of type 2 diabetes. The scientific community is becoming more interested in curcumin, one of these therapeutic herbs. The plant Curcuma longa, often known as turmeric, has a bioactive compound called curcumin in its rhizome. Antioxidant, cardio-protective, anti-inflammatory, anti-microbial, nephro-protective, anti-neoplastic, hepato-protective, immunomodulatory, hypoglycemic, and anti-rheumatic effects are among the various pharmacological and biological effects of curcumin that have been reported by both in vitro and in vivo studies. Curcumin extract increases -cell functioning, delays the onset of diabetes, inhibits -cell death, and lowers insulin resistance in animal models. Recent preclinical studies and clinical trials have shown strong evidence of curcumin's vital roles in preventing type 2 diabetes via a number of pathways. Thus, the antidiabetic action of curcumin and its many mechanisms are comprehensively summarized in this study. The findings indicated that curcumin's anti-inflammatory, anti-oxidant, antihyperglycemic, antiapoptotic, and antihyperlipidemic properties, among others, account for its success in treating type 2 diabetes. These findings suggest that curcumin could be a potential option for T2DM prevention and management.</p>\",\"PeriodicalId\":11451,\"journal\":{\"name\":\"Drug Research\",\"volume\":\" \",\"pages\":\"251-260\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2604-4115\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2604-4115","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

2型糖尿病(T2DM)是一种复杂的、多方面的代谢性疾病,正成为一个重大的公共卫生问题。由于草药中的生物活性化合物具有许多生物学特性,在多项研究中已被证明对预防和控制2型糖尿病具有积极作用。科学界对姜黄素越来越感兴趣,姜黄素是这些治疗草药之一。姜黄(Curcuma longa),通常被称为姜黄,它的根茎中含有一种叫做姜黄素的生物活性化合物。抗氧化、心脏保护、抗炎、抗微生物、肾保护、抗肿瘤、肝保护、免疫调节、降血糖和抗风湿病作用是姜黄素在体外和体内研究中报道的各种药理学和生物学作用。姜黄素提取物增加细胞功能,延缓糖尿病的发作,抑制细胞死亡,降低动物模型中的胰岛素抵抗。最近的临床前研究和临床试验已经强有力地证明了姜黄素通过多种途径在预防2型糖尿病中发挥重要作用。本文就姜黄素的抗糖尿病作用及其多种机制作一综述。研究结果表明,姜黄素的抗炎、抗氧化、降糖、抗细胞凋亡和抗高脂血症等特性是其成功治疗2型糖尿病的原因。这些发现表明姜黄素可能是预防和管理2型糖尿病的潜在选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Curcumin in Type 2 Diabetes Mellitus: A Natural Approach to Modulating Metabolic Dysfunction.

A complex and multifaceted metabolic disease, type 2 diabetes mellitus (T2DM) is becoming a significant public health concern. Due to their many biological characteristics, bioactive compounds from herbal medicine have been shown in multiple studies to have positive benefits on the prevention and control of type 2 diabetes. The scientific community is becoming more interested in curcumin, one of these therapeutic herbs. The plant Curcuma longa, often known as turmeric, has a bioactive compound called curcumin in its rhizome. Antioxidant, cardio-protective, anti-inflammatory, anti-microbial, nephro-protective, anti-neoplastic, hepato-protective, immunomodulatory, hypoglycemic, and anti-rheumatic effects are among the various pharmacological and biological effects of curcumin that have been reported by both in vitro and in vivo studies. Curcumin extract increases -cell functioning, delays the onset of diabetes, inhibits -cell death, and lowers insulin resistance in animal models. Recent preclinical studies and clinical trials have shown strong evidence of curcumin's vital roles in preventing type 2 diabetes via a number of pathways. Thus, the antidiabetic action of curcumin and its many mechanisms are comprehensively summarized in this study. The findings indicated that curcumin's anti-inflammatory, anti-oxidant, antihyperglycemic, antiapoptotic, and antihyperlipidemic properties, among others, account for its success in treating type 2 diabetes. These findings suggest that curcumin could be a potential option for T2DM prevention and management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Research
Drug Research PHARMACOLOGY & PHARMACY-
CiteScore
3.50
自引率
0.00%
发文量
67
期刊介绍: Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. Publishing twelve times a year, Drug Research includes original research articles as well as reviews, commentaries and short communications in the following areas: analytics applied to clinical trials chemistry and biochemistry clinical and experimental pharmacology drug interactions efficacy testing pharmacodynamics pharmacokinetics teratology toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信